ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,064.20
0.00%
Dow Jones
38,225.66
0.00%
US Dollar vs MXN
16.85196
-0.71%
Brent Oil
83.725
0.11%
Bitcoin
60,974.88
3.14%
Registration Strip Icon for discussion Regístrate para interactuar en nuestros foros activos para discutir con inversores de ideas afines.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. SurModics Inc (SRDX)

  7. SurModics Inc (SRDX) Noticias

SRDX SurModics Inc

34.55
0.00 (0.00%)
Pre Mercado
Última actualización: 06:50:26
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
SurModics Inc SRDX NASDAQ Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
Upgrade Icon
0.00 0.00% 34.55 06:50:26
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
34.55
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
01/5/202406:00BWSurmodics Reports Second Quarter of Fiscal Year 2024..
19/4/202406:00BWSurmodics to Report Second Quarter of Fiscal 2024 Financial..
27/2/202407:00BWSurmodics to Participate in Upcoming Investor Conferences in..
12/2/202415:22EDGAR2Form 8-K - Current report
12/2/202415:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/2/202415:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/2/202415:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/2/202415:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/2/202415:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/2/202410:20EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
07/2/202415:27EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/2/202408:53EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
01/2/202407:15EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
01/2/202406:00EDGAR2Form 8-K - Current report
01/2/202406:00BWSurmodics Reports First Quarter of Fiscal Year 2024..
29/1/202415:29EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
23/1/202416:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/1/202406:30BWSurmodics Announces Successful Early Clinical Use of Pounce™..
16/1/202406:30BWSurmodics to Host Virtual Annual Meeting of Shareholders
03/1/202415:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/12/202315:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/12/202315:05EDGAR2Form DEF 14A - Other definitive proxy statements
18/12/202315:05EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
06/12/202315:48EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/12/202315:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/12/202315:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/12/202315:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/12/202315:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/12/202315:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/12/202316:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/12/202316:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/12/202316:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/12/202316:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/12/202316:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/12/202316:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/12/202316:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/11/202309:22EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
17/11/202315:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/11/202315:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/11/202306:30BWSurmodics Announces TRANSCEND Trial 36-Month Data Presented..
14/11/202315:05BWSurmodics to Participate in the Piper Sandler Healthcare..
08/11/202306:30BWSurmodics Reports Fourth Quarter and Fiscal Year 2023..
08/11/202306:00EDGAR2Form 8-K - Current report
07/11/202306:30BWSurmodics Announces SWING Trial 24-Month Data to be..
31/10/202306:30BWSurmodics Announces Launch of Preside™ Medical Device..
10/10/202306:30BWSurmodics to Report Fourth Quarter and Fiscal 2023 Financial..
03/10/202315:49EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/8/202316:05BWSurmodics to Participate in Upcoming Investor Conferences in..
02/8/202307:16EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
02/8/202306:31BWSurmodics Reports Third Quarter of Fiscal Year 2023..

Su Consulta Reciente

NASDAQ
SRDX
SurModics
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados